Ellis E N, Brouhard B H, Lagrone L, Travis L B
Diabetes Care. 1983 May-Jun;6(3):251-5. doi: 10.2337/diacare.6.3.251.
N-acetyl-beta-D-glucosaminidase (NAG), a lysosomal enzyme, has been shown to be increased in the urine of patients with various glomerulonephritides, tubulointerestitial diseases, renal allograft rejection, toxic renal injury, and diabetes mellitus. Although it has been suggested that urinary NAG may reflect blood glucose control, no studies have correlated this with other measures of metabolic control. Thirty-four children from a diabetic summer camp were found to have urinary NAG to creatinine ratios significantly above those of normal controls of similar age (5.22 +/- 1.19 versus 1.51 +/- 0.17 U). Urinary NAG was found to positively correlate with an arbitrary control index (r = 0.82; P less than 0.05) and in seven patients with hemoglobin A1c (r = 0.70; P less than 0.001). In a closely followed group of 40 clinic patients, urinary NAG to creatinine ratio was again found to be significantly increased over normal controls (7.55 +/- 0.70 versus 1.51 +/- 0.17 U; P less than 0.05). Again, urinary NAG was positively correlated with HbA1c (r = 0.62; P less than 0.001) and urinary albumin to creatinine ratio (r = 0.47; P less than 0.01). In neither group was there a correlation with UNAG:UCr and duration of disease. Thus, these data suggest that urinary NAG to creatinine ratio appears to be a reflection of blood sugar control.
N-乙酰-β-D-氨基葡萄糖苷酶(NAG)是一种溶酶体酶,已证实在患有各种肾小球肾炎、肾小管间质疾病、肾移植排斥反应、中毒性肾损伤和糖尿病的患者尿液中该酶水平会升高。尽管有人提出尿NAG可能反映血糖控制情况,但尚无研究将其与其他代谢控制指标相关联。研究发现,来自糖尿病夏令营的34名儿童尿NAG与肌酐的比值显著高于年龄相仿的正常对照组(5.22±1.19对1.51±0.17 U)。尿NAG与一个任意控制指数呈正相关(r = 0.82;P<0.05),在7名血红蛋白A1c患者中也呈正相关(r = 0.70;P<0.001)。在一组密切随访的40名门诊患者中,再次发现尿NAG与肌酐的比值显著高于正常对照组(7.55±0.70对1.51±0.17 U;P<0.05)。同样,尿NAG与糖化血红蛋白(r = 0.62;P<0.001)和尿白蛋白与肌酐的比值呈正相关(r = 0.47;P<0.01)。在这两组中,尿NAG与肌酐比值(UNAG:UCr)和病程均无相关性。因此,这些数据表明尿NAG与肌酐的比值似乎反映了血糖控制情况。